4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company: Oruka Therapeutics, Inc.
Filed: December 11, 2025
Period of Report: December 11, 2025
Accession Number: 0000907654-25-000019

View Document ↗ View on SEC.gov ↗